CCL-2 released by tumor cells, macrophages, and stromal cells within the TME recruits monocytes that express the receptor CCR-2 and granulocytes (i.e. myeloid-derived suppressor cells; MDSCs) that express the receptor CCR-5 to tumors, thereby driving tumor progression. This evidence concerns the gene CCR2 and neoplasm.